Log In
Print this Print this

buprenorphine hemiadipate (RBP-6300)

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionAbuse-deterrent tablet formulation of buprenorphine using Capsugel drug delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAddiction
Indication DetailsTreat opioid dependence
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today